 | • レポートコード：D0GIR-10589 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、降圧薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。降圧薬の種類別市場規模（利尿薬、アンジオテンシン受容体遮断薬（ARB）、アンジオテンシン変換酵素（ACE）阻害剤、ベータ遮断薬、アルファ遮断薬、カルシウムチャネル遮断薬、レニン阻害薬、血管拡張薬）、用途別市場規模（病院、クリニック、家庭）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Astra Zeneca、Merck、Novartis、Johnson & Johnson、Sanofi、Ranbaxy、Lupin、Boehringer Ingelheim、Daiichi Sankyo ・地域別グローバル市場分析 2015年-2020年 ・降圧薬の北米市場（アメリカ、カナダ、メキシコ） ・降圧薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・降圧薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・降圧薬の南米市場（ブラジル、アルゼンチン） ・降圧薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：利尿薬、アンジオテンシン受容体遮断薬（ARB）、アンジオテンシン変換酵素（ACE）阻害剤、ベータ遮断薬、アルファ遮断薬、カルシウムチャネル遮断薬、レニン阻害薬、血管拡張薬 ・用途別分析：病院、クリニック、家庭 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Antihypertensive market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 21480 million by 2025, from USD 19810 million in 2019.
The Antihypertensive market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antihypertensive market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antihypertensive market has been segmented into
Diuretics
Angiotensin receptorblockers (ARBs)
Angiotensin converting enzyme (ACE) inhibitors
Beta blockers
Alpha blockers
Calcium channel blockers
Renin inhibitors
Vasodilators
By Application, Antihypertensive has been segmented into:
Hosptial
Clinic
Home
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antihypertensive market presented in the report. This section sheds light on the sales growth of different regional and country-level Antihypertensive markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antihypertensive market.
The report offers in-depth assessment of the growth and other aspects of the Antihypertensive market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Antihypertensive Market Share Analysis
Antihypertensive competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antihypertensive sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antihypertensive sales, revenue and market share for each player covered in this report.
The major players covered in Antihypertensive are:
Pfizer
Astra Zeneca
Merck
Novartis
Johnson & Johnson
Sanofi
Ranbaxy
Lupin
Boehringer Ingelheim
Daiichi Sankyo
Among other players domestic and global, Antihypertensive market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antihypertensive product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antihypertensive, with price, sales, revenue and global market share of Antihypertensive in 2018 and 2019.
Chapter 3, the Antihypertensive competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antihypertensive breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antihypertensive market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antihypertensive sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antihypertensive Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Diuretics
1.2.3 Angiotensin receptorblockers (ARBs)
1.2.4 Angiotensin converting enzyme (ACE) inhibitors
1.2.5 Beta blockers
1.2.6 Alpha blockers
1.2.7 Calcium channel blockers
1.2.8 Renin inhibitors
1.2.9 Vasodilators
1.3 Market Analysis by Application
1.3.1 Overview: Global Antihypertensive Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hosptial
1.3.3 Clinic
1.3.4 Home
1.4 Overview of Global Antihypertensive Market
1.4.1 Global Antihypertensive Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Astra Zeneca
2.2.1 Astra Zeneca Details
2.2.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Astra Zeneca SWOT Analysis
2.2.4 Astra Zeneca Product and Services
2.2.5 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ranbaxy
2.7.1 Ranbaxy Details
2.7.2 Ranbaxy Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ranbaxy SWOT Analysis
2.7.4 Ranbaxy Product and Services
2.7.5 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lupin
2.8.1 Lupin Details
2.8.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lupin SWOT Analysis
2.8.4 Lupin Product and Services
2.8.5 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Daiichi Sankyo SWOT Analysis
2.10.4 Daiichi Sankyo Product and Services
2.10.5 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antihypertensive Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antihypertensive Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antihypertensive Manufacturer Market Share in 2019
3.3.2 Top 6 Antihypertensive Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antihypertensive Sales, Revenue and Market Share by Regions
4.1.1 Global Antihypertensive Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antihypertensive Revenue and Market Share by Regions (2015-2020)
4.2 North America Antihypertensive Sales and Growth Rate (2015-2020)
4.3 Europe Antihypertensive Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antihypertensive Sales and Growth Rate (2015-2020)
4.5 South America Antihypertensive Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antihypertensive Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antihypertensive Sales, Revenue and Market Share by Country
5.1.1 North America Antihypertensive Sales and Market Share by Country (2015-2020)
5.1.2 North America Antihypertensive Revenue and Market Share by Country (2015-2020)
5.2 United States Antihypertensive Sales and Growth Rate (2015-2020)
5.3 Canada Antihypertensive Sales and Growth Rate (2015-2020)
5.4 Mexico Antihypertensive Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antihypertensive Sales, Revenue and Market Share by Country
6.1.1 Europe Antihypertensive Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antihypertensive Revenue and Market Share by Country (2015-2020)
6.2 Germany Antihypertensive Sales and Growth Rate (2015-2020)
6.3 UK Antihypertensive Sales and Growth Rate (2015-2020)
6.4 France Antihypertensive Sales and Growth Rate (2015-2020)
6.5 Russia Antihypertensive Sales and Growth Rate (2015-2020)
6.6 Italy Antihypertensive Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antihypertensive Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antihypertensive Revenue and Market Share by Regions (2015-2020)
7.2 China Antihypertensive Sales and Growth Rate (2015-2020)
7.3 Japan Antihypertensive Sales and Growth Rate (2015-2020)
7.4 Korea Antihypertensive Sales and Growth Rate (2015-2020)
7.5 India Antihypertensive Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antihypertensive Sales and Growth Rate (2015-2020)
7.7 Australia Antihypertensive Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antihypertensive Sales, Revenue and Market Share by Country
8.1.1 South America Antihypertensive Sales and Market Share by Country (2015-2020)
8.1.2 South America Antihypertensive Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antihypertensive Sales and Growth Rate (2015-2020)
8.3 Argentina Antihypertensive Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antihypertensive Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antihypertensive Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antihypertensive Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antihypertensive Sales and Growth Rate (2015-2020)
9.3 Turkey Antihypertensive Sales and Growth Rate (2015-2020)
9.4 Egypt Antihypertensive Sales and Growth Rate (2015-2020)
9.5 South Africa Antihypertensive Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antihypertensive Sales and Market Share by Type (2015-2020)
10.2 Global Antihypertensive Revenue and Market Share by Type (2015-2020)
10.3 Global Antihypertensive Price by Type (2015-2020)
11 Global Antihypertensive Market Segment by Application
11.1 Global Antihypertensive Sales Market Share by Application (2015-2020)
11.2 Global Antihypertensive Revenue Market Share by Application (2015-2020)
11.3 Global Antihypertensive Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antihypertensive Sales, Revenue and Growth Rate (2021-2025)
12.2 Antihypertensive Market Forecast by Regions (2021-2025)
12.2.1 North America Antihypertensive Market Forecast (2021-2025)
12.2.2 Europe Antihypertensive Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antihypertensive Market Forecast (2021-2025)
12.2.4 South America Antihypertensive Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antihypertensive Market Forecast (2021-2025)
12.3 Antihypertensive Market Forecast by Type (2021-2025)
12.3.1 Global Antihypertensive Sales Forecast by Type (2021-2025)
12.3.2 Global Antihypertensive Market Share Forecast by Type (2021-2025)
12.4 Antihypertensive Market Forecast by Application (2021-2025)
12.4.1 Global Antihypertensive Sales Forecast by Application (2021-2025)
12.4.2 Global Antihypertensive Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Antihypertensive Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antihypertensive by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antihypertensive Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Antihypertensive Major Business
Table 9. Pfizer Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Antihypertensive Product and Services
Table 12. Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 14. Astra Zeneca Antihypertensive Major Business
Table 15. Astra Zeneca Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 16. Astra Zeneca SWOT Analysis
Table 17. Astra Zeneca Antihypertensive Product and Services
Table 18. Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Antihypertensive Major Business
Table 21. Merck Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 22. Merck SWOT Analysis
Table 23. Merck Antihypertensive Product and Services
Table 24. Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Antihypertensive Major Business
Table 27. Novartis Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Antihypertensive Product and Services
Table 30. Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Antihypertensive Major Business
Table 33. Johnson & Johnson Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 34. Johnson & Johnson SWOT Analysis
Table 35. Johnson & Johnson Antihypertensive Product and Services
Table 36. Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi Antihypertensive Major Business
Table 39. Sanofi Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 40. Sanofi SWOT Analysis
Table 41. Sanofi Antihypertensive Product and Services
Table 42. Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Ranbaxy Basic Information, Manufacturing Base and Competitors
Table 44. Ranbaxy Antihypertensive Major Business
Table 45. Ranbaxy Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 46. Ranbaxy SWOT Analysis
Table 47. Ranbaxy Antihypertensive Product and Services
Table 48. Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Lupin Basic Information, Manufacturing Base and Competitors
Table 50. Lupin Antihypertensive Major Business
Table 51. Lupin Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 52. Lupin SWOT Analysis
Table 53. Lupin Antihypertensive Product and Services
Table 54. Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 56. Boehringer Ingelheim Antihypertensive Major Business
Table 57. Boehringer Ingelheim Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 58. Boehringer Ingelheim SWOT Analysis
Table 59. Boehringer Ingelheim Antihypertensive Product and Services
Table 60. Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 62. Daiichi Sankyo Antihypertensive Major Business
Table 63. Daiichi Sankyo Antihypertensive Total Revenue (USD Million) (2018-2019)
Table 64. Daiichi Sankyo SWOT Analysis
Table 65. Daiichi Sankyo Antihypertensive Product and Services
Table 66. Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Antihypertensive Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Antihypertensive Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Antihypertensive Sales by Regions (2015-2020) (K Units)
Table 70. Global Antihypertensive Sales Market Share by Regions (2015-2020)
Table 71. Global Antihypertensive Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Antihypertensive Sales by Countries (2015-2020) (K Units)
Table 73. North America Antihypertensive Sales Market Share by Countries (2015-2020)
Table 74. North America Antihypertensive Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Antihypertensive Revenue Market Share by Countries (2015-2020)
Table 76. Europe Antihypertensive Sales by Countries (2015-2020) (K Units)
Table 77. Europe Antihypertensive Sales Market Share by Countries (2015-2020)
Table 78. Europe Antihypertensive Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Antihypertensive Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Antihypertensive Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Antihypertensive Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Antihypertensive Sales by Countries (2015-2020) (K Units)
Table 83. South America Antihypertensive Sales Market Share by Countries (2015-2020)
Table 84. South America Antihypertensive Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Antihypertensive Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Antihypertensive Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Antihypertensive Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Antihypertensive Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Antihypertensive Revenue Market Share by Countries (2015-2020)
Table 90. Global Antihypertensive Sales by Type (2015-2020) (K Units)
Table 91. Global Antihypertensive Sales Share by Type (2015-2020)
Table 92. Global Antihypertensive Revenue by Type (2015-2020) (USD Million)
Table 93. Global Antihypertensive Revenue Share by Type (2015-2020)
Table 94. Global Antihypertensive Sales by Application (2015-2020) (K Units)
Table 95. Global Antihypertensive Sales Share by Application (2015-2020)
Table 96. Global Antihypertensive Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Antihypertensive Market Share Forecast by Regions (2021-2025)
Table 98. Global Antihypertensive Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Antihypertensive Market Share Forecast by Type (2021-2025)
Table 100. Global Antihypertensive Sales Forecast by Application (2021-2025)
Table 101. Global Antihypertensive Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antihypertensive Picture
Figure 2. Global Sales Market Share of Antihypertensive by Type in 2019
Figure 3. Diuretics Picture
Figure 4. Angiotensin receptorblockers (ARBs) Picture
Figure 5. Angiotensin converting enzyme (ACE) inhibitors Picture
Figure 6. Beta blockers Picture
Figure 7. Alpha blockers Picture
Figure 8. Calcium channel blockers Picture
Figure 9. Renin inhibitors Picture
Figure 10. Vasodilators Picture
Figure 11. Antihypertensive Sales Market Share by Application in 2018
Figure 12. Hosptial Picture
Figure 13. Clinic Picture
Figure 14. Home Picture
Figure 15. Global Antihypertensive Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Antihypertensive Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Antihypertensive Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Antihypertensive Sales Market Share by Manufacturer in 2019
Figure 36. Global Antihypertensive Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Antihypertensive Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Antihypertensive Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Antihypertensive Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Antihypertensive Revenue Market Share by Regions (2015-2020)
Figure 43. Global Antihypertensive Revenue Market Share by Regions in 2018
Figure 44. North America Antihypertensive Sales and Growth Rate (2015-2020)
Figure 45. Europe Antihypertensive Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Antihypertensive Sales and Growth Rate (2015-2020)
Figure 47. South America Antihypertensive Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Antihypertensive Sales and Growth Rate (2015-2020)
Figure 49. North America Antihypertensive Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Antihypertensive Sales Market Share by Countries (2015-2020)
Figure 51. North America Antihypertensive Sales Market Share by Countries in 2018
Figure 52. North America Antihypertensive Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Antihypertensive Revenue Market Share by Countries in 2018
Figure 54. United States Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Antihypertensive Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Antihypertensive Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Antihypertensive Revenue Market Share by Countries in 2019
Figure 60. Germany Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Antihypertensive Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Antihypertensive Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Antihypertensive Revenue Market Share by Regions 2019
Figure 68. China Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Antihypertensive Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Antihypertensive Sales Market Share by Countries in 2019
Figure 75. South America Antihypertensive Revenue Market Share by Countries in 2019
Figure 76. Brazil Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Antihypertensive Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Antihypertensive Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Antihypertensive Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Antihypertensive Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Antihypertensive Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Antihypertensive Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Antihypertensive Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Antihypertensive Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Antihypertensive Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Antihypertensive Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Antihypertensive Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Antihypertensive Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
アンジオテンシン変換酵素阻害薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Angiotensin Converting Enzyme Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …- バーター症候群薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome Drugs…
- バーター症候群治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome T…
- 眼科用レンズブロッカーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Ophthalmic Lens Blockers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 高血圧及び心不全治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Hypertension and Heart Failure Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …